Tetra Bio-Pharma Inc. today announced the appointment of Richard Giguère to the position of Chief Executive Officer of Tetra Natural Health Inc. a newly created, wholly owned subsidiary of Tetra Bio-Pharma Inc.
Tetra Bio-Pharma Inc. today announced the permanent appointment of Guy Chamberland, Ph.D., as CEO and CSO having most recently held the position of CEO in an interim capacity. Dr. Chamberland has more than 23 years' experience in the development of new drugs in the North American pharmaceutical industry.
Tetra Bio-Pharma Inc. today announced it received the response letter for a Type C meeting with the United States Food and Drug Administration (FDA) for PPP002, its dronabinol AdVersa™ mucoadhesive product.
Tetra Bio-Pharma Inc., in partnership with Ford’s Family Pharmacy and Wellness Center, have developed and implemented a pharmaceutical quality system for Canada’s first botanical-based prescription drug PPP001.
Tetra Bio-Pharma Inc. today announced that it conducted a Type B meeting with the United States Food and Drug Administration (FDA) for its dronabinol AdVersa™ mucoadhesive product, PPP002.
Tetra Bio-Pharma Inc. has made significant progress in its clinical trial for PPP005 the cannabis oil-based capsules destined for the natural health products market.
Tetra Bio-Pharma Inc. has made significant progress in its co-development partnership with Storz & Bickel. The study protocol has received approval from the Independent Ethics Board (IRB Services) and was recently submitted for review to Health Canada.
Tetra Bio-Pharma Inc. announced today that Health Canada has re-classified the inhalation pipe device used in the delivery of its PPP001 cannabis drug to a Class 2 Medical Device.
Tetra Bio-Pharma Inc. announced today that it is accelerating the submission of a pre-marketing application for the registration of its cannabis drugs PPP001 and PPP005 under Directive 2001/83/EC of the European Parliament and of the Council.
Tetra Bio-Pharma Inc. is pleased to announce that it has secured a CBD supply agreement with True North Cannabis in Alberta, Canada.